Riskpilot← Back to searchSign inGet full accessKJEMIXPERT AS
ASActiveOrg 986417257Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20040 employeeskjemixpert.no
Revenue 2022
NOK 0
EBITDA margin
—
+3% vs 2021
Equity ratio
99.7%
Financial strength
Net profit 2022
NOK -239K
+24% vs 2021
| Revenue | NOK 0 | — |
| EBITDA | NOK -293K | +3% |
| Net profit | NOK -239K | +24% |
| Total assets | NOK 9,6M | -2% |
| Equity | NOK 9,5M | -2% |
| Employees | 0 | — |
Legal name
KJEMIXPERT AS
Org number
986417257
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. januar 2004
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg, service og support av instrumentering og forbruksartikler til laboratoriemarkedet, konsulenttjenester i form av markedsføring, salg og bedriftsrådgivning, samt annen virksomhet som naturlig hører til, herunder deltakelse i tilknyttet virksomhet.
Address
Website
kjemixpert.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 5 878 | 5 714 | 2 625 | 0 | 0 |
| Staff expenses | −324 | −150 | −153 | −153 | −153 |
| EBITDA | 2 205 | 2 249 | 767 | −303 | −293 |
| Depreciation & amort. | −0 | −0 | −0 | −8 | −8 |
| EBIT | 2 205 | 2 249 | 767 | −311 | −301 |
| Net financials | −24 | 43 | 32 | −3 | 62 |
| Profit before tax | 2 181 | 2 292 | 799 | −315 | −239 |
| Tax | 502 | 504 | 176 | −0 | −0 |
| Net profit | 1 680 | 1 788 | 623 | −315 | −239 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 10 450 | 10 240 | 10 313 | 9 792 | 9 551 |
| Equity | 7 664 | 9 452 | 10 074 | 9 760 | 9 521 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 787 | 789 | 238 | 32 | 30 |
| Total debt | 2 787 | 789 | 238 | 32 | 30 |
EBITDA margin
-29255900.0%
This company
15.8%
Market median
-185164024% vs market
20182022
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20182022
Return on equity
-2.5%
This company
18.4%
Market median
-114% vs market
20182022
Net profit margin
-23889700.0%
This company
8.1%
Market median
-294934668% vs market
20182022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SE Deputy Member | Deputy Member | 2004 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2004 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KJEMIXPERT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stine Eriksen | Deputy Member | 0 companies |
| Trond Bekker-Larsen | Chairman | 0 companies |